News, trends & global reports for pharma and biotech manufacturers, suppliers & scientists - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

News
The top business, scientific and regulatory news from the pharmaceutical and biotechnology industries.

EMA Works to Speed Up Ebola Treatment

October 20, 2014

The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.

AbbVie/Shire Deal Officially Off

October 20, 2014

AbbVie to pay Shire $1.635 billion break fee for terminating purchase agreement.

Lilly to Close Manufacturing Facility in Puerto Rico

October 17, 2014

Lilly announces the closure of its Guayama, Puerto Rico manufacturing facility amid continued investments at other plants.

Harnessing the Power of Modified T Cells to Treat Cancer

October 17, 2014

Personalized immunotherapy treatments help 90% of acute lymphoblastic leukemia patients achieve remission in a new study.

Genentech Announces FDA Approval of Idiopathic Pulmonary Fibrosis Treatment

October 17, 2014

Genentech announced FDA-approved Esbriet for the treatment of Idiopathic Pulmonary Fibrosis.

FDA Approves OFEV for the Treatment of Idiopathic Pulmonary Fibrosis

October 17, 2014

Boehringer Ingelheim's OFEV was approved by FDA as the first treatment for idiopathic pulmonary fibrosis, a fatal lung disease.

Pfizer Ireland Plant Receives ISPE Award

October 16, 2014

Pfizer's addition of a new vaccine suite and multiproduct bioprocess suite to its Ireland facility win the company the title of 2014 Facility of the Year.

Hospira Recalls Certain Lots of Intravenous Products

October 15, 2014

Hospira voluntary recalls certain lots of several LifeCare products due to potential for leakage.

AbbVie Reconsiders Shire Offer

October 15, 2014

AbbVie sends Shire notice that it is reconsidering its offer recommendation.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
9%
All of the above.
43%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here